These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28624434)

  • 1. Brain glucose metabolism: Role of Wnt signaling in the metabolic impairment in Alzheimer's disease.
    Cisternas P; Inestrosa NC
    Neurosci Biobehav Rev; 2017 Sep; 80():316-328. PubMed ID: 28624434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease.
    Cisternas P; Zolezzi JM; Martinez M; Torres VI; Wong GW; Inestrosa NC
    J Neurochem; 2019 Apr; 149(1):54-72. PubMed ID: 30300917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt5a Increases the Glycolytic Rate and the Activity of the Pentose Phosphate Pathway in Cortical Neurons.
    Cisternas P; Salazar P; Silva-Álvarez C; Barros LF; Inestrosa NC
    Neural Plast; 2016; 2016():9839348. PubMed ID: 27688915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhang L; Sun C; Jin Y; Gao K; Shi X; Qiu W; Ma C; Zhang L
    J Alzheimers Dis; 2017; 60(2):733-746. PubMed ID: 28922151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models of Alzheimer's disease: cellular and molecular aspects.
    Hoyer S
    J Neural Transm Suppl; 1997; 49():11-21. PubMed ID: 9266410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy metabolism and inflammation in brain aging and Alzheimer's disease.
    Yin F; Sancheti H; Patil I; Cadenas E
    Free Radic Biol Med; 2016 Nov; 100():108-122. PubMed ID: 27154981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
    Liu L; Wan W; Xia S; Kalionis B; Li Y
    Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis.
    Cisternas P; Salazar P; Silva-Álvarez C; Barros LF; Inestrosa NC
    J Biol Chem; 2016 Dec; 291(50):25950-25964. PubMed ID: 27703002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain.
    Abolhassani N; Leon J; Sheng Z; Oka S; Hamasaki H; Iwaki T; Nakabeppu Y
    Mech Ageing Dev; 2017 Jan; 161(Pt A):95-104. PubMed ID: 27233446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming energetic metabolism in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Life Sci; 2018 Jan; 193():141-152. PubMed ID: 29079469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe/PS1dE9 mice.
    Wang P; Su C; Feng H; Chen X; Dong Y; Rao Y; Ren Y; Yang J; Shi J; Tian J; Jiang S
    Int J Immunopathol Pharmacol; 2017 Mar; 30(1):25-43. PubMed ID: 28124574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?
    Blum-Degen D; Frölich L; Hoyer S; Riederer P
    J Neural Transm Suppl; 1995; 46():139-47. PubMed ID: 8821049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice.
    Galea E; Feinstein DL; Lacombe P
    Diabetologia; 2006 Sep; 49(9):2153-61. PubMed ID: 16830140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The starving brain: Overfed meets undernourished in the pathology of mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    Gibas KJ
    Neurochem Int; 2017 Nov; 110():57-68. PubMed ID: 28899812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology.
    Caricasole A; Bakker A; Copani A; Nicoletti F; Gaviraghi G; Terstappen GC
    Biosci Rep; 2005; 25(5-6):309-27. PubMed ID: 16307379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.